RTI Biologics, Inc. (RTIX) Reports In-Line Q4 EPS; Guides Below Street
Tweet Send to a Friend
RTI Biologics, Inc. (NASDAQ: RTIX) reported Q4 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
